Skip to main content

Stress Urinary Incontinence (Male)

Male stress urinary incontinence (SUI) is involuntary urine loss with physical exertion, cough, sneeze, or Valsalva. In contemporary reconstructive practice it is overwhelmingly an incontinence-after-prostate-treatment problem: radical prostatectomy, radiation, and outlet surgery can injure the external rhabdosphincter, bladder-neck support, periurethral tissues, and pelvic innervation.[1][2][3] The AUA/GURS/SUFU Incontinence After Prostate Treatment guideline anchors contemporary evaluation, counseling, and procedural selection.[4]

This page covers the clinical framework — who has it, how to grade it, when to intervene. For the operative options and selection criteria, see the Male SUI treatment database.

Epidemiology and Etiology​

Post-prostatectomy (the dominant cause)​

After radical prostatectomy, reported SUI prevalence spans a wide range depending on definition, follow-up, and measurement method — 5–60% at 3–6 months, with most resolving by 12 months.[1][2][5] Persistent incontinence beyond one year — the threshold at which surgical intervention is typically considered — affects roughly 5–20% of post-RP patients in modern cohorts.[4][6]

Risk factors for persistent post-RP SUI:[4][6]

  • Advancing age
  • Higher BMI
  • Preoperative LUTS / baseline urethral function
  • Longer membranous urethral length on preoperative MRI (protective)
  • Nerve-sparing status
  • Surgeon volume and technique
  • Prior or subsequent radiation therapy

Other causes​

  • TURP / HoLEP / other BPH surgery — SUI is uncommon but clinically important when apical resection, prior radiation, or sphincter injury compromises the external sphincter.[4]
  • Pelvic trauma — external urethral sphincter damage with pelvic fracture urethral injury
  • Neurogenic — lesions of the thoracolumbar sympathetic outflow (T11–L2) impair proximal urethral tone; sacral lesions (S2–S4) affect the rhabdosphincter; pelvic plexus destruction, cauda equina compression, and selected spinal cord lesions can similarly unmask sphincteric leakage.[7]
  • Post-cystectomy neobladder — continence depends on an intact external sphincter; SUI here is a distinct problem from reservoir function

Pathophysiology​

Male SUI is fundamentally an intrinsic sphincter deficiency (ISD) problem.[1][2] After prostatectomy, three mechanisms compound:

  1. Direct rhabdosphincter injury during apical dissection
  2. Loss of the proximal continence mechanism — bladder neck and prostatic urethra no longer contribute
  3. Local denervation from pelvic plexus or pudendal-branch injury

Radiation adds progressive fibrosis of the membranous urethra, stiffens the sphincter, and over years can convert a well-compensated patient into a leaker.

Detrusor overactivity, impaired compliance, and bladder-neck contracture can coexist with sphincter deficiency and produce a mixed incontinence picture. The reconstructive consequence is practical: bladder-only management rarely resolves leakage with a sphincteric driver, and sling or AUS planning is unsafe until obstruction, poor compliance, infection, and dominant urgency symptoms have been addressed.[4][6]

Diagnosis and Evaluation​

Initial workup​

  • History — onset relative to surgery, pad count (pads-per-day, PPD), pad weight, activities that provoke leakage, nocturnal vs daytime distribution, prior radiation, comorbidities, medications
  • Validated instruments — ICIQ-SF, UDI-6, IPSS for mixed LUTS[4]
  • 3-day voiding diary with pad weights
  • Physical exam — standing cough stress test, perineal sensation, anal tone, DRE (post-RP anatomy)
  • Urinalysis + culture to rule out UTI
  • Post-void residual — bladder US or catheter
  • 24-hour pad test — preferred objective severity measure before surgery[4]

See Assessment Tools & Questionnaires for instrument detail.

Specialized evaluation​

Before any surgical intervention, or if SUI persists ≥ 12 months:[4][6]

  • Urodynamics — confirms ISD (low abdominal leak-point pressure, low maximum urethral closure pressure), documents compliance and detrusor overactivity, excludes occult retention
  • Cystoscopy — bladder neck contracture, vesicourethral anastomotic stricture, urethral stones; bladder neck contracture is a critical pre-surgical finding because it must be treated before sling or AUS
  • MRI (selected) — membranous urethral length if planning anatomic sling

Red flags deserving expedited referral: gross hematuria, new obstructive symptoms, recurrent UTIs, suspected fistula.

Severity grading​

The practical severity bands drive surgical selection:[4][8]

SeverityPads/day24-h pad weightTypical surgical option
Mild1–2 PPD<100 gSling, bulking, or observation
Moderate3–5 PPD100–400 gSling or AUS (patient preference; radiation favors AUS)
Severe>5 PPD, continuous leak>400 gAUS

Radiation history shifts selection toward AUS at any severity because radiated tissue is a poor sling bed and a high-risk erosion environment.

Natural History and Timing of Intervention​

Post-RP SUI follows a predictable recovery curve. The AUA/GURS/SUFU guideline and contemporary series support:[4][5][6]

  • 0–6 months: expect ongoing recovery; do not offer surgery absent a specific indication (severe non-improving leakage, patient in acute distress)
  • 6–12 months: continue conservative management; pelvic floor muscle training is most effective when started early, although trial quality and protocols are heterogeneous[9]
  • ≥ 12 months: persistent SUI is unlikely to resolve spontaneously; surgical evaluation is appropriate

A minority of men with severe persistent early SUI (e.g., continuous leakage at 6 months with no improvement trajectory) warrant earlier formal evaluation. The guideline emphasizes shared decision-making and bounds rather than rigid timelines.[4]

Management​

Conservative (first 6–12 months)​

  • Pelvic floor muscle training — first-line; Cochrane evidence supports possible benefit, but the certainty is limited by small heterogeneous trials and inconsistent PFMT protocols[9]
  • Lifestyle — fluid and caffeine management, weight loss, smoking cessation
  • Biofeedback-augmented PFMT — may accelerate learning but is not clearly superior to PFMT alone long-term[9]
  • Electrical stimulation (surface, perineal, or anal stimulation) — evidence is mixed and generally low certainty; use as an adjunct rather than a substitute for supervised PFMT[10]
  • Penile compression (clamp) — temporizing only; chronic use risks urethral erosion and skin necrosis

Pharmacotherapy has no proven role in pure male SUI. Duloxetine, antimuscarinics, β3-agonists, phosphodiesterase inhibitors, and α-adrenergic agents have been described for post-RP urinary symptoms, but medications mainly treat urgency-predominant or mixed LUTS rather than the sphincteric leak itself.[6]

Surgical options — overview​

Treatment selection integrates severity, radiation history, urethral and cognitive factors, and patient preference. For detailed selection criteria and outcomes see the Male SUI treatment database. In order of typical escalation:

OptionBest candidateKey consideration
Urethral bulkingMild, patient declining sling/AUSLow efficacy, limited durability; office-based
Male urethral slingMild to moderate, no radiation, intact urethraPassive, no device to operate; best outcomes in low pad-weight patients
Adjustable continence device (ProACT)Selected mild-to-moderate SUI where availablePostoperative titration is the main draw; evidence and availability vary by region
Artificial urinary sphincter (AUS)Moderate to severe; radiation; revision settingGold standard — durable efficacy; patient must be able to operate the pump

Historical autologous fascial slings and Burch-style suspensions have been largely replaced by the options above, though the principle of compression/support under the bulbar urethra persists.[2][11]

Outcomes​

InterventionKey outcomeReference
PFMTMay hasten early continence recovery after prostate surgery; certainty remains limited by trial heterogeneityJohnson Cochrane 2023[9]
Urethral slingBest outcomes in non-irradiated mild-to-moderate SUI; failure risk rises with high pad weight, prior radiation, and poor urethral mobilitySandhu 2010; Prebay 2023[2][11]
AUSMost durable option for moderate-to-severe post-prostate-treatment SUI; revisions are expected over long follow-upAUA/GURS/SUFU 2024; Sandhu 2010[4][2]
BulkingShort-term symptomatic improvement; durability limited and repeat injection commonSilva Cochrane 2014[12]

Radiation degrades outcomes across every modality; AUS in the radiated patient has higher erosion and revision rates but remains the most effective option.

Complications to Counsel​

AUS-specific: mechanical failure, cuff erosion (higher with radiation), infection requiring explant, atrophy requiring downsizing or reposition, need for patient dexterity to cycle the pump.

Sling-specific: perineal pain, inability to catheterize in retention, sling release if obstructive, mesh-related complications (rare but present).

Bulking-specific: migration, repeat injections, limited durability.

Shared: urinary retention, UTI, de novo or persistent overactive bladder symptoms.

See Also​

References​

1. Koch GE, Kaufman MR. "Male Stress Urinary Incontinence." Urol Clin North Am. 2022;49(3):403-418. doi:10.1016/j.ucl.2022.04.005

2. Sandhu JS. "Treatment Options for Male Stress Urinary Incontinence." Nat Rev Urol. 2010;7(4):222-8. doi:10.1038/nrurol.2010.26

3. Radadia KD, Farber NJ, Shinder B, et al. "Management of Postradical Prostatectomy Urinary Incontinence: A Review." Urology. 2018;113:13-19. doi:10.1016/j.urology.2017.09.025

4. Breyer BN, Kim SK, Kirkby E, Marianes A, Vanni AJ, Westney OL. "Updates to Incontinence After Prostate Treatment: AUA/GURS/SUFU Guideline (2024)." J Urol. 2024;212(4):531-538. doi:10.1097/JU.0000000000004088

5. Sacco E, Prayer-Galetti T, Pinto F, et al. "Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up." BJU Int. 2006;97(6):1234-1241. doi:10.1111/j.1464-410X.2006.06185.x

6. Castellan P, Ferretti S, Litterio G, Marchioni M, Schips L. "Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions." Ther Clin Risk Manag. 2023;19:43-56. doi:10.2147/TCRM.S283305

7. Ginsberg DA, Boone TB, Cameron AP, et al. "The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation." J Urol. 2021;206(5):1097-1105. doi:10.1097/JU.0000000000002235

8. Wolfe AR, Khouri RK Jr, Bhanvadia RR, et al. "Male stress urinary incontinence is often underreported." Can J Urol. 2021;28(2):10589-10594. PMID:33872555

9. Johnson EE, Mamoulakis C, Stoniute A, Omar MI, Sinha S. "Conservative Interventions for Managing Urinary Incontinence After Prostate Surgery." Cochrane Database Syst Rev. 2023;4:CD014799. doi:10.1002/14651858.CD014799.pub2

10. Berghmans B, Hendriks E, Bernards A, de Bie R, Omar MI. "Electrical Stimulation With Non-Implanted Electrodes for Urinary Incontinence in Men." Cochrane Database Syst Rev. 2013;(6):CD001202. doi:10.1002/14651858.CD001202.pub5

11. Prebay ZJ, Foss HE, Wang KR, Chung PH. "A narrative review on surgical treatment options for male stress urinary incontinence." Transl Androl Urol. 2023;12(5):874-886. doi:10.21037/tau-22-629

12. Silva LA, Andriolo RB, Atallah ÁN, da Silva EM. "Surgery for Stress Urinary Incontinence Due to Presumed Sphincter Deficiency After Prostate Surgery." Cochrane Database Syst Rev. 2014;(9):CD008306. doi:10.1002/14651858.CD008306.pub3